• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在卫生政策中优先考虑吸毒者:澳大利亚首都地区案例研究。

Prioritising people who use drugs in health policy: An Australian Capital Territory case study.

作者信息

Bowles Devin, Yar Elisabeth, van der Sterren Anke

机构信息

ACT Council of Social Service, Canberra, Australia.

Faculty of Health, University of Canberra, Canberra, Australia.

出版信息

Drug Alcohol Rev. 2025 Mar;44(3):685-695. doi: 10.1111/dar.14001. Epub 2025 Feb 17.

DOI:10.1111/dar.14001
PMID:39957331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11886498/
Abstract

INTRODUCTION

Governments are increasingly identifying priority populations on which to focus health policy and to measure health and wellbeing outcomes. Prioritising populations that are considered to be higher risk or to have particular needs that may not be captured within the parameters of health policy developed for the general population, is essential to health equity and efficient resource allocation. However, the criteria that governments use for prioritising populations is often vague or unspecified. To date, people who use drugs are almost never identified as a priority population in health policy, despite poor health and wellbeing outcomes.

METHODS

We developed three-pronged criteria-disadvantage, prevalence/accessibility and amenability to change-for prioritising populations in government health policy. We used these criteria to compare people who access alcohol, tobacco and other drug (ATOD) services with populations which are prioritised within the Australian Capital Territory Government's Wellbeing Framework.

RESULTS

Use of the criteria indicates that health policy prioritisation of people who access ATOD services is warranted. People who access ATOD services experienced worse health and wellbeing outcomes across all measures.

DISCUSSION AND CONCLUSIONS

Given increasingly explicit prioritisation of populations in health policy, there is an opportunity to advance health equity and embed policy efficiency through formal and transparent consideration of which populations to prioritise. Using set criteria for prioritising populations in health policy is possible, and could help identify populations often overlooked for prioritisation, such as people who access ATOD services.

摘要

引言

各国政府越来越多地确定重点人群,以便将卫生政策聚焦于这些人群,并衡量健康和福祉成果。对那些被认为风险较高或有特殊需求(而这些需求可能无法在为普通人群制定的卫生政策范围内得到满足)的人群进行优先排序,对于实现健康公平和有效资源分配至关重要。然而,政府用于对人群进行优先排序的标准往往模糊不清或未明确规定。迄今为止,尽管吸毒者的健康和福祉状况不佳,但他们在卫生政策中几乎从未被确定为重点人群。

方法

我们制定了一个三管齐下的标准——劣势、患病率/可及性和可改变性——用于在政府卫生政策中对人群进行优先排序。我们使用这些标准将使用酒精、烟草和其他毒品(ATOD)服务的人群与澳大利亚首都直辖区政府福祉框架中被优先考虑的人群进行比较。

结果

使用这些标准表明,有必要在卫生政策中对使用ATOD服务的人群进行优先排序。在所有衡量指标中,使用ATOD服务的人群的健康和福祉状况都更差。

讨论与结论

鉴于卫生政策中对人群的优先排序越来越明确,有机会通过正式和透明地考虑对哪些人群进行优先排序来促进健康公平并提高政策效率。在卫生政策中使用既定标准对人群进行优先排序是可行的,并且有助于识别那些在优先排序中经常被忽视的人群,例如使用ATOD服务的人群。

相似文献

1
Prioritising people who use drugs in health policy: An Australian Capital Territory case study.在卫生政策中优先考虑吸毒者:澳大利亚首都地区案例研究。
Drug Alcohol Rev. 2025 Mar;44(3):685-695. doi: 10.1111/dar.14001. Epub 2025 Feb 17.
2
Australian federal, state and territory policy on the health and wellbeing of young people: A scoping review.澳大利亚联邦、州和地区的青年健康与福利政策:范围综述。
Health Policy. 2021 Aug;125(8):1065-1076. doi: 10.1016/j.healthpol.2021.05.017. Epub 2021 May 31.
3
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
4
Alcohol and other drug use by Australian workers: insights from a nationally representative cross-sectional survey.澳大利亚工人的酒精和其他药物使用情况:来自全国代表性横断面调查的见解。
Health Promot Int. 2025 Mar 5;40(2). doi: 10.1093/heapro/daaf048.
5
Systems for the management of respiratory disease in primary care - an international series: Australia.基层医疗中呼吸系统疾病管理系统——国际系列:澳大利亚
Prim Care Respir J. 2008 Mar;17(1):19-25. doi: 10.3132/pcrj.2008.00015.
6
An evaluation of the discriminant and predictive validity of relative social disadvantage as screening criteria for priority access to public general dental care, in Australia.澳大利亚对相对社会劣势作为优先获得公共普通牙科护理筛查标准的判别效度和预测效度的评估。
BMC Health Serv Res. 2014 Mar 4;14:106. doi: 10.1186/1472-6963-14-106.
7
Australia in 2030: what is our path to health for all?2030 年的澳大利亚:全民健康之路在何方?
Med J Aust. 2021 May;214 Suppl 8:S5-S40. doi: 10.5694/mja2.51020.
8
Equity consideration in palliative care policies, programs, and evaluation: an analysis of selected federal and South Australian documents.在姑息治疗政策、计划和评估中的公平性考虑:对选定的联邦和南澳大利亚文件的分析。
BMC Palliat Care. 2022 Jun 16;21(1):109. doi: 10.1186/s12904-022-00997-2.
9
Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.改善物质使用障碍康复期学生行为和学业成果的康复学校:一项系统综述
Campbell Syst Rev. 2018 Oct 4;14(1):1-86. doi: 10.4073/csr.2018.9. eCollection 2018.
10
Improving access to general practice for and with people with severe and multiple disadvantage: a qualitative study.改善严重多重弱势群体获得全科医疗服务的机会:一项定性研究。
Br J Gen Pract. 2024 Apr 25;74(742):e330-e338. doi: 10.3399/BJGP.2023.0244. Print 2024 May.

本文引用的文献

1
Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions.阿片类药物激动剂治疗者自付费用的经济分析:澳大利亚三个司法管辖区的横断面调查。
Int J Drug Policy. 2022 Jan;99:103472. doi: 10.1016/j.drugpo.2021.103472. Epub 2021 Oct 11.
2
Impact evaluations of drug decriminalisation and legal regulation on drug use, health and social harms: a systematic review.药物非刑事化和法律监管对药物使用、健康及社会危害的影响评估:一项系统综述
BMJ Open. 2020 Sep 21;10(9):e035148. doi: 10.1136/bmjopen-2019-035148.
3
Life expectancy of people who are dependent on opioids: A cohort study in New South Wales, Australia.依赖阿片类药物人群的预期寿命:来自澳大利亚新南威尔士州的一项队列研究。
J Psychiatr Res. 2020 Nov;130:435-440. doi: 10.1016/j.jpsychires.2020.08.013. Epub 2020 Aug 23.
4
The Relative Risk of Homelessness among Persons with a Disability: New Methods and Policy Insights.残疾人士无家可归的相对风险:新方法和政策见解。
Int J Environ Res Public Health. 2019 Nov 6;16(22):4304. doi: 10.3390/ijerph16224304.
5
Linkages Between Incarceration and Health.监禁与健康的关联。
Public Health Rep. 2019 May/Jun;134(1_suppl):8S-14S. doi: 10.1177/0033354919826563.
6
Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model.加大丙型肝炎防治力度以实现消除目标:全球数学模型。
Lancet. 2019 Mar 30;393(10178):1319-1329. doi: 10.1016/S0140-6736(18)32277-3. Epub 2019 Jan 29.
7
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.1990 - 2016年195个国家和地区因酒精和药物使用所致的全球疾病负担:全球疾病负担研究2016的系统分析
Lancet Psychiatry. 2018 Dec;5(12):987-1012. doi: 10.1016/S2215-0366(18)30337-7. Epub 2018 Nov 1.
8
Estimating the number of people who inject drugs in Australia.估算澳大利亚注射毒品者的人数。
BMC Public Health. 2017 Sep 29;17(1):757. doi: 10.1186/s12889-017-4785-7.
9
Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?到2030年在注射毒品者中将丙型肝炎作为一个公共卫生问题消除——实现这一目标需要什么?
J Int AIDS Soc. 2017 Jul 28;20(1):22146. doi: 10.7448/IAS.20.1.22146.
10
Stigma and substance use disorders: an international phenomenon.耻辱感与物质使用障碍:一种国际现象。
Curr Opin Psychiatry. 2017 Sep;30(5):378-388. doi: 10.1097/YCO.0000000000000351.